Details of the Drug
General Information of Drug (ID: DMG5MJL)
| Drug Name |
Phosphoric acid monotetradecyl ester
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Tetradecyl dihydrogen phosphate; UNII-DF6HW7A5EB; 1-Tetradecanol, dihydrogen phosphate; 10054-29-2; Phosphoric acid monotetradecyl ester; DF6HW7A5EB; CHEMBL187633; 69029-24-9; myristyl phosphate; EINECS 233-184-8; AC1Q6T1O; SCHEMBL375578; AC1L336V; Phosphoric acid tetradecyl ester; DTXSID1073995; BDBM50170842
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 294.37 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 5.1 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 14 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


